SI2556074T1 - Triciklična indazolna spojina, postopek priprave in farmacevtski sestavek, ki jo vsebuje - Google Patents

Triciklična indazolna spojina, postopek priprave in farmacevtski sestavek, ki jo vsebuje

Info

Publication number
SI2556074T1
SI2556074T1 SI201130421T SI201130421T SI2556074T1 SI 2556074 T1 SI2556074 T1 SI 2556074T1 SI 201130421 T SI201130421 T SI 201130421T SI 201130421 T SI201130421 T SI 201130421T SI 2556074 T1 SI2556074 T1 SI 2556074T1
Authority
SI
Slovenia
Prior art keywords
preparation
pharmaceutical composition
composition containing
indazole compound
tricyclic indazole
Prior art date
Application number
SI201130421T
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Beatrice Garrone
Gabriele Magaro'
Giorgina Mangano
Original Assignee
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A filed Critical Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A
Publication of SI2556074T1 publication Critical patent/SI2556074T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI201130421T 2010-04-08 2011-03-04 Triciklična indazolna spojina, postopek priprave in farmacevtski sestavek, ki jo vsebuje SI2556074T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10159346 2010-04-08
EP20110708766 EP2556074B1 (en) 2010-04-08 2011-03-04 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
PCT/EP2011/053270 WO2011124430A1 (en) 2010-04-08 2011-03-04 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it

Publications (1)

Publication Number Publication Date
SI2556074T1 true SI2556074T1 (sl) 2015-04-30

Family

ID=42664839

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130421T SI2556074T1 (sl) 2010-04-08 2011-03-04 Triciklična indazolna spojina, postopek priprave in farmacevtski sestavek, ki jo vsebuje

Country Status (26)

Country Link
US (2) US9120801B2 (sl)
EP (1) EP2556074B1 (sl)
JP (1) JP5739980B2 (sl)
KR (1) KR20130045239A (sl)
CN (1) CN102812028B (sl)
AR (1) AR080835A1 (sl)
AU (1) AU2011238054B2 (sl)
BR (1) BR112012023539A2 (sl)
CA (1) CA2788762C (sl)
CY (1) CY1116246T1 (sl)
DK (1) DK2556074T3 (sl)
EA (1) EA021417B1 (sl)
ES (1) ES2532534T3 (sl)
GE (1) GEP20135997B (sl)
HK (1) HK1179962A1 (sl)
HR (1) HRP20150325T1 (sl)
IL (1) IL221244A (sl)
MX (1) MX2012011231A (sl)
PL (1) PL2556074T3 (sl)
PT (1) PT2556074E (sl)
RS (1) RS53859B1 (sl)
SG (1) SG183168A1 (sl)
SI (1) SI2556074T1 (sl)
SM (1) SMT201500066B (sl)
UA (1) UA108747C2 (sl)
WO (1) WO2011124430A1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016201649A (ja) * 2015-04-09 2016-12-01 キヤノン株式会社 撮像装置、撮像システム、および撮像装置の駆動方法
CA3068254A1 (en) 2017-06-20 2018-12-27 Imbria Pharmaceuticals, Inc. Compositions and methods for increasing efficiency of cardiac metabolism
CN109336890B (zh) * 2018-11-17 2020-03-20 重庆文理学院 一种吲唑类衍生物的合成方法及抗肿瘤应用
JP7504118B2 (ja) * 2019-03-13 2024-06-21 ザ ロックフェラー ユニバーシティ 自己炎症性疾患及びがん転移を治療するためのｃＧＡＳ阻害剤
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360819A1 (en) * 2001-12-28 2003-07-24 Bayer Corporation Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
DE102004054665A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende

Also Published As

Publication number Publication date
UA108747C2 (uk) 2015-06-10
GEP20135997B (en) 2013-12-25
SMT201500066B (it) 2015-05-05
CY1116246T1 (el) 2017-04-26
PT2556074E (pt) 2015-03-04
CA2788762C (en) 2018-04-10
CA2788762A1 (en) 2011-10-13
IL221244A (en) 2016-02-29
US9655906B2 (en) 2017-05-23
HK1179962A1 (en) 2013-10-11
KR20130045239A (ko) 2013-05-03
SG183168A1 (en) 2012-09-27
JP5739980B2 (ja) 2015-06-24
BR112012023539A2 (pt) 2017-10-03
CN102812028A (zh) 2012-12-05
IL221244A0 (en) 2012-10-31
AU2011238054B2 (en) 2016-06-23
HRP20150325T1 (hr) 2015-04-24
JP2013523790A (ja) 2013-06-17
EP2556074A1 (en) 2013-02-13
US9120801B2 (en) 2015-09-01
AR080835A1 (es) 2012-05-09
CN102812028B (zh) 2014-11-12
ES2532534T3 (es) 2015-03-27
MX2012011231A (es) 2012-11-12
AU2011238054A1 (en) 2012-08-23
EA201291014A1 (ru) 2013-03-29
WO2011124430A1 (en) 2011-10-13
US20150320763A1 (en) 2015-11-12
US20130023524A1 (en) 2013-01-24
EA021417B1 (ru) 2015-06-30
PL2556074T3 (pl) 2015-06-30
DK2556074T3 (en) 2015-03-23
EP2556074B1 (en) 2015-01-21
RS53859B1 (en) 2015-08-31

Similar Documents

Publication Publication Date Title
HK1199255A1 (en) Indazole compounds, compositions and methods of use
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
EP2582664A4 (en) PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
HK1179962A1 (en) Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
IL232577A0 (en) The history of morpholinylbenzotriazine, their preparation and pharmaceutical preparations containing them
SI2281822T1 (sl) Novi derivati dihidroindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2504331A4 (en) COMPOUND, SOME NEW FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF PREPARATION AND USE
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
IL231505B (en) Pharmaceutical preparation and method for its production
IL230219B (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
EP2285215A4 (en) NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD OF USE THEREOF
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL230907A0 (en) Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
HUP1100532A2 (en) Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
EP2565180A4 (en) ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
IL225378A0 (en) History of phenylquinazoline, their preparation and pharmaceutical preparations containing them
IL208957A0 (en) Pharmaceutical gallium compounds, composition and methods of preparation
EP2543373A4 (en) PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND
PL2497774T3 (pl) Pochodne dihydro-oksazolobenzodiazepinonu, sposoby ich wytwarzania i kompozycje farmaceutyczne zawierające te związki
HU1000591D0 (en) Stabilized pharmaceutical compositions containing capsaicin and process for their preparation
HU1000455D0 (en) Solid composition for killing slugs and process for its preparation